Increasing Screening for Cancer Using EHR-Nudges Replication

In this study, personalized nudges to clinicians and patients will be evaluated to help increase breast cancer screening rates in accordance with USPSTF guidelines among women with a primary care visit. In partnership with Penn Medicine (Penn) and Case Western Reserve University-University Hospitals (UH), two complementary, concurrent 6-month, cluster randomized, pragmatic trials were conducted from December 2023 to October 2024. This trial will now replicate those interventions at Lancaster General Health (LGH), incorporating learnings from the primary trials while also adapting to align with existing health system protocols and policies. The patient nudge interventions include pre- and post-visit text message reminders to encourage the patient to schedule their mammogram, and the clinician nudge intervention includes a Smart Data Element message in the electronic health record (EHR) reminding the care team that the patient is overdue and that patients are more likely to complete their screening if recommended and ordered by their clinician.

NCT Number	NCT06995703
Lead Sponsor	Abramson Cancer Center at Penn Medicine Collaborators: National Institute on Aging (NIA)
Conditions	Breast Cancer
Enrollment	8,490 participants
Start Date	2025-06-02
Primary Completion	2026-03-02 (estimated)
Study Completion	2026-06-02 (estimated)
Updated on ClinicalTrials.gov	2026-08-12